Inhibition of the de-myelinating properties of Aicardi-Goutières syndrome lymphocytes by cathepsin D silencing.

[1]  John H Livingston,et al.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature , 2012, Nature Genetics.

[2]  J. S. Ahn,et al.  Cathepsin D inhibits oxidative stress-induced cell death via activation of autophagy in cancer cells. , 2012, Cancer letters.

[3]  I. Sanz,et al.  Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome , 2012, Current opinion in rheumatology.

[4]  R. Skolasky,et al.  Dysregulation of Macrophage-Secreted Cathepsin B Contributes to HIV-1-Linked Neuronal Apoptosis , 2012, PloS one.

[5]  M. Longobardi,et al.  Inhibition of neuroblastoma cell growth by TREX1-mutated human lymphocytes. , 2012, Oncology reports.

[6]  S. Fulda,et al.  Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro. , 2012, Molecular immunology.

[7]  D. Stetson,et al.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. , 2012, Immunity.

[8]  C. Cartiglia,et al.  Different Mutations in Three Prime Repair Exonuclease 1 and Ribonuclease H2 Genes Affect Clinical Features in Aicardi-Goutières Syndrome , 2012, Journal of child neurology.

[9]  C. Cartiglia,et al.  The Aicardi-Goutières syndrome. Molecular and clinical features of RNAse deficiency and microRNA overload. , 2011, Mutation research.

[10]  M. Wabl,et al.  An autoimmune disease prevented by anti-retroviral drugs , 2011, Retrovirology.

[11]  Se-Jin Kim,et al.  Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival , 2011, Amino Acids.

[12]  Kenji F. Tanaka,et al.  Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination , 2011, Journal of neuroscience research.

[13]  T. Nyman,et al.  Recognition of Cytoplasmic RNA Results in Cathepsin-Dependent Inflammasome Activation and Apoptosis in Human Macrophages , 2011, The Journal of Immunology.

[14]  A. Cuervo,et al.  Induction of Autophagy by Cystatin C: A Mechanism That Protects Murine Primary Cortical Neurons and Neuronal Cell Lines , 2010, PloS one.

[15]  C. Cartiglia,et al.  Interferon‐Related Transcriptome Alterations in the Cerebrospinal Fluid Cells of Aicardi‐Goutières Patients † , 2009, Brain pathology.

[16]  T. Heidmann,et al.  Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.

[17]  C. Cartiglia,et al.  BRAIN DAMAGE AS DETECTED BY cDNA-MICROARRAY IN THE SPINAL FLUID OF PATIENTS WITH AICARDI-GOUTIÈRES SYNDROME , 2008, Neurology.

[18]  K. Suk,et al.  Neurotoxicity of microglial cathepsin D revealed by secretome analysis , 2007, Journal of neurochemistry.

[19]  F. Shi,et al.  Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. , 2007, Arthritis and rheumatism.

[20]  Kenji F. Tanaka,et al.  Induced Expression of Cathepsins and Cystatin C in a Murine Model of Demyelination , 2007, Neurochemical Research.

[21]  S. Scott,et al.  Cathepsin D-mediated proteolysis of apolipoprotein E: Possible role in Alzheimer’s disease , 2006, Neuroscience.

[22]  D. Barnes,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.

[23]  C. Ponting,et al.  Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.

[24]  Guido Kroemer,et al.  Caspase-independent cell death , 2005, Nature Medicine.

[25]  H. Huls,et al.  Isolation and immortalization of lymphocytes. , 2005, Current protocols in molecular biology.

[26]  J. Dennis,et al.  The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies , 2005, Journal of Cell Science.

[27]  R. González-Amaro,et al.  Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE). , 2001, Immunology letters.

[28]  J. Kay,et al.  Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation. , 1997, Journal of immunology.

[29]  P. Barth,et al.  Aicardi-Goutières syndrome , 2020, Definitions.

[30]  J. Kos,et al.  Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. , 1988, Biochemical and biophysical research communications.